European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Video / Webinar

Life Sciences & Pharma

Navigating China's Volume-Based Procurement in the Pharma Industry

August 27, 2025

Life Sciences & Pharma

Prescription for Progress: A Health Equity Maturity Framework for Pharma Companies

June 12, 2025

Published Articles

Life Sciences & Pharma

The Growth of Radiotherapeutics: Addressing Supply Chain Complexity

May 21, 2025

Executive Insights

Life Sciences & Pharma

When Is It Too Late? Drivers of Commercial Performance for Late Entrants in Biopharma

April 28, 2025

Video / Webinar

Healthcare Services

Australia's Clinical Trials: Innovation and Growth

February 24, 2025

Executive Insights

Life Sciences & Pharma

Future Outlook for the AOM Market

January 9, 2025